Abstract
Background:
P. diazotrophicus was isolated from a newborn with D-galactosemia complicated sepsis. A homologous blaCAR-2 gene, encoding CAR-2, a predicted member of the CAR family subclass B3 metallo-β-lactamases (MBLs), was found in the genome of this strain. This study aimed to explore the identification of a novel CAR-2 protein encoded by the chromosome of P. diazotrophicus Pd1 that exhibits the zinc-binding motifs of subclass B3 enzymes and the regulatory pattern of CARR, located directly upstream of the blaCAR-2 gene, on the blaCAR-2 gene and its impact on antibiotic resistance.
Methods:
Antibiotic susceptibility testing was conducted by the plate agar dilution method. Site-directed mutagenesis was conducted using Mut Express II Fast Mutagenesis Kit V2. Kinetic assays were used to determine the hydrolysis of β-Lactam. The construction of bacterial knockout strains was carried out according to the principle of homologous recombination. The detection of the mRNA expression level of the gene was performed by Real-time Quantitative PCR (qPCR).
Results:
The minimum inhibitory concentrations (MICs) for E.coli DH5α(pHSG398::CAR-2), which expressed blaCAR-2, increased significantly for cefalothin, cefuroxime and cefotaxime sodium by 2-, 16- and 32- fold, respectively, which showed that blaCAR-2 had resistance to these three antibiotics. This protein, which was a MBL, contains two classical zinc-binding sites characteristic of subclass B3, with the amino acid motif His136, His138, His211, Asp140, His141, and His276. Among the six residues, His136, Asp140, and His211 exhibited the highest catalytic activity. We determined that CAR-2 can effectively hydrolyze cefalothin, cefuroxime and cefotaxime. The chloramphenicol resistance of the constructed E. coli DH5α strain was significantly reduced in the presence of CARR than in the absence of CARR. Compared with those for the wild-type P. diazotrophicus, MICs of cefalothin, cefuroxime and cefotaxime for the ΔCARR strain increased by 8-, 8- and 16-fold, respectively, and the expression level of blaCAR-2 also increased by approximately 10-fold.
Conclusion:
Overall, CAR-2 is a novel subclass B3 MBL of the CAR family that exhibits catalytic activity against cefalothin, cefuroxime and cefotaxime. CARR represses the expression of blaCAR-2, thereby reducing the resistance of P. diazotrophicus to these antibiotics. This provided a theoretical basis for revealing new mechanisms of pathogen resistance.
Introduction
Phytobacter diazotrophicus (P. diazotrophicus) belongs to the Enterobacteriaceae family and was initially identified as a gram-negative bacterium that promotes plant growth. Subsequently, this species has been associated with opportunistic infections in humans and nosocomial settings (; ). The clinical significance of P. diazotrophicus has likely been underestimated due to frequent misidentification of clinical isolates as other Enterobacteriaceae (). β-lactam antibiotics are the primary therapeutic agents for treating infections caused by P. diazotrophicus. In the past 2 years, clinical reports have described the emergence of multidrug-resistant P. diazotrophicus strains (; ). In 2010, The Lancet Infectious Disease published an article on the New Delhi metallo-β-lactamase-1 (NDM-1) superbug, which attracted widespread public and scientific attention (). The increased global use of antibiotics has contributed to the rise of NDM-1-producing superbugs (). NDM-1-producing P. diazotrophicus strains have been detected in hospitalized patients and healthcare environments (). Currently, metallo-β-lactamase (MBL)-producing pathogens represent a major threat to clinical treatment options ().
Clinically, Ambler classifies β-lactamases into four categories: A, B, C, and D (). Among them, the active sites of classes A, C, and D are serine residues; they are also known as serine-β-lactamases. In contrast, class B enzymes require metal ion coordination at the active site and are referred to as MBLs. Many novel MBLs have been speculated to originate from environmental bacteria, which serve as a large reservoir of antibiotic resistance genes that can be transferred into pathogenic bacteria (). MBLs can hydrolyze a broad spectrum of β-lactam antibiotics, except for monobactams, and their activity can be inhibited by metal ion-chelating agents such as EDTA, phenanthroline, and sulfhydryl compounds (). Class B MBLs are further divided into three subclasses, B1, B2, and B3, based on their amino acid sequences, structural features, and the number of zinc ion-binding sites (). Subclass B3 is classified separately from B1 and B2 due to its extremely low sequence homology with the other subclasses. Most characterized subclass B3 MBLs have been discovered in environmental bacteria, but have been increasingly identified in clinical samples (). The discovery of Adelaide Imipenemase (AIM-1), a subclass B3 MBL in Pseudomonas aeruginosa (P. aeruginosa) that efficiently hydrolyzes a wide range of β-lactam antibiotics and performs better than subclass B1 MBLs such as IMP-1 and VIM-2, suggests that the functional significance of subclass B3 MBLs has been underestimated (). Given the increasing prevalence of antibiotic resistance, the absence of effective MBL inhibitors in clinical practice has become an urgent concern ().
We isolated and cultured gram-negative bacilli from the blood of a newborn with D-galactosemia complicated by sepsis. This strain was successfully identified as P. diazotrophicus, named P. diazotrophicus Pd1 (). The genome of this strain carries gene_2795, a homolog of blaCAR. To facilitate its distinction from the previously reported blaCAR-1 gene (locus number: ECA2849) and its encoded protein CAR-1, our research group named the gene_2795 in P. diazotrophicus as blaCAR-2, and its encoded protein CAR-2. Previous literature reported that the CAR-1 protein, the CAR family, subclass B3 MBLs, can effectively hydrolyze broad-spectrum β-lactam antibiotics (). In the genome of P. diazotrophicus Pd1, directly upstream of blaCAR-2 is gene_2796, which is divergently transcribed relative to blaCAR-2 gene and encodes a LysR-type transcriptional regulatory protein. This gene was named the CAR-related regulator (CARR). However, the mechanism of action of the CAR-2 protein and the CARR regulatory protein in emerging pathogenic bacteria, as well as the regulatory relationship between CARR and the blaCAR-2 gene, remain unclear.
Herein, we report the identification of a novel CAR-2 protein encoded by the chromosome of P. diazotrophicus Pd1 that exhibits the zinc-binding motifs of subclass.
B3 enzymes. By constructing active mutants of the CAR-2 protein, the active site of this protein was determined based on changes in antibiotic susceptibility testing. To clarify the function of the CAR-2 protein in hydrolyzing antibiotics, we conducted kinetic measurements. In this study, through gene knockout and expression analysis, we explored the regulatory pattern of CARR on the blaCAR-2 gene and its impact on antibiotic resistance.
Materials and methods
Bacterial strains and culture conditions
P. diazotrophicus Pd1, E. coli DH5α and E. coli BL21(DE3) were preserved in our laboratory. E. coli DH5α served as the host for constructing recombinant plasmids. E. coli BL21(DE3) was used for the induced expression of the CAR-2 protein. E. coli S17-1(λpir) was purchased from Beyotime Biotechnology and was used for constructing suicide plasmid. P. diazotrophicus Pd1 was cultured on a blood agar plate at 37°C. The draft complete sequences of P. diazotrophicus Pd1 was deposited in NCBI GenBank under the accession number: PRJNA1020661.
Sequence analysis for CAR-2
To clarify the similarity between predicted CAR-2 and other β-lactamases, we conducted the analysis through the Beta-lactamase database (BLDB)-structure and function BLAST analysis (http://www.bldb.eu:4567/). The signal peptide was predicted through protein signal peptide prediction (https://www.novopro.cn/tools/signalp). The molecular mass and predicted isoelectric point of CAR-2 were estimated using ExPASy(https://web.expasy.org/compute_pi/).
Expression of blaCAR-2 in E. coli DH5α
A pHSG398::CAR-2 construct was generated to test the β-lactam substrate specificity of CAR-2, as described previously (). High-fidelity PCR was used to amplify the complete coding frame sequence of blaCAR-2 with the forward primer EcoRI-blaCAR-2-F and the reverse primer PstI-blaCAR-2-R. The primer design was carried out using Primer 5 software with the following parameter settings: annealing temperature is 58–62°C, primer length is 18–24 bp, and GC content is 40–60%. Primer sequences are shown in Supplementary Table S1. High-fidelity PCR was purchased from Vazyme. The total reaction volume of 50 µL consisted of 20 µL ddH2O, 25 µL 2× Phanta Max Master Mix, 2 µL primer F, 2 µL primer R, and 1 µL template DNA. The thermal cycle was programmed for 3 min at 95°C for pre-denaturation, followed by 32 cycles of 15 s at 95°C for denaturation, 15 s at 60°C for annealing, 60 s at 72°C for extension; a final extension was conducted for 5 min at 72°C. The PCR product and the pHSG398 plasmid (Takara) were double-digested with EcoRI and PstI, and then the PCR product was ligated to the pHSG398 plasmid using T4 ligase. The restriction enzymes EcoRI and PstI were purchased from Thermo Fisher Scientific. Using the forward primer EcoRI-blaCAR-2-F and the reverse primer PstI-blaCAR-2-R, PCR was performed to verify that the recombinant pHSG398 plasmid was successfully connected and transformed into E. coli DH5α, which was named E.coli DH5α(pHSG398::CAR-2). This recombinant strain expresses blaCAR-2 under the control of the lac promoter. Similarly, using the forward primer Test-pHSG398-F and the rear primer Test-pHSG398-R, PCR was performed to confirm the successful transformation of the empty pHSG398 plasmid into E. coli DH5α, which was named E.coli DH5α(pHSG398). This strain was used as a negative control.
Antibiotic susceptibility testing
The minimum inhibitory concentration (MIC) values of susceptibility of strains to 14 kinds of β-lactam antibiotics including ampicillin, piperacillin, carbenicillin, cefalotin, cefoxitin, cefuroxime, ceftazidime, cefotaxime, ceftazidime/clavulanic acid, cefepime, aztreonam, imipenem, meropenem, and ertapenem were detected by the Mueller-Hinton (MH) agar plate dilution method. Antibiotics were purchased from Aladdin Biochemical Technology Co., Ltd. In brief, we first revived strains on a blood plate for 24 hours, then picked single clones and subcultured them for 24 hours. Subsequently we added each antibiotic with a serial dilution concentration to an empty plate, and then poured 25 mL of MH agar medium at about 50°C into each plate. Next, we adjusted the bacterial suspension concentration to 0.5 McFarland turbidity standard with a McFarland turbidimeter, and titrated 1 μL of the bacterial suspension onto the surface of the MH agarplates. After air-drying, finally we placed the plates in an incubator at 37°C, and observed the MIC values of each strain 20 hours later. E. coli ATCC8739 was selected as the quality control bacterium. Repeat the biological experiment three times.
For determination of blaCAR-2 MBL activity, MIC values of 14 kinds of β-lactam antibiotics were also determined in the presence of 0.2 mM EDTA to demonstrate the reduction in the blaCAR-2 activity due to metal chelation.
Construction of mutations at the key active sites of the CAR-2 protein
To test the key active sites of the CAR-2 protein, we constructed six single mutants (H136A, H138A, H211A, D140A, H141A, and H276A) in E. coli DH5α. Site-directed mutagenesis was conducted using Mut Express II Fast Mutagenesis Kit V2 (Vazyme Biotech Co., Ltd). Briefly, the codons corresponding to the amino acid residues His136, His138, His211, Asp140, His141, and His276 were replaced with the codon GCC, corresponding to alanine(A), at the 5’ end of the primers. Primer sequences are listed in Supplementary Table S1. Using pHSG398::CAR-2 plasmid DNA as a template, six single mutant plasmids—pHSG398::CAR-2(H136A), pHSG398::CAR-2(H138A), pHSG398::CAR-2(H211A), pHSG398::CAR-2(D140A), pHSG398::CAR-2(H141A), and pHSG398::CAR-2(H276A)—were amplified with the primer pairs mentioned above. Subsequently, these plasmids were individually transformed into E. coli DH5α. Sanger sequencing (first-generation sequencing) using the forward primer Sanger-F and the rear primer Sanger-R was performed to determine the ~650 bp region containing the mutation site. Sequence alignment using the Chromas software confirmed the successful construction of all six single mutant strains.
Induced expression and purification of recombinant CAR-2 protein
Firstly, we used high-fidelity PCR to amplify the coding frame sequence (removing the signal peptide sequence) of blaCAR-2 with the forward primer NdeI-CAR-2-F and the reverse primer XhoI-CAR-2-R. The restriction enzymes NdeI and XhoI were purchased from Thermo Fisher Scientific. Primer sequences was showed in Supplementary Table S1. The PCR product and pET-21b(+) were double-digested with NdeI and XhoI, and then PCR product ligated to the pET-21b(+) plasmid using T4 ligase. Using the forward primer NdeI-CAR-2-F and the reverse primer XhoI-CAR-2-R, PCR was performed to verify that the Recombinant pET-21b(+) plasmid was successfully transformed into E. coli BL21(DE3), which was named E. coli BL21(DE3) (pET-21b-CAR-2). A single clone of E. coli BL21(DE3) (pET-21b-CAR-2) was added to 500 mL of liquid LB medium and cultured at 37°C and 220 rpm/min for 9 hours. Subsequently, we added IPTG to the bacterial culture to a final concentration of 0.5 mM and then incubated it on a shaker overnight at 37°C.The bacterial culture was collected by centrifugation at 5000rpm/min for 5 minutes and resuspended in a Tris·HCl buffer solution containing 20 mM imidazole. The bacteria were lysed by sonication (power 30%, sonication time 45 min, on for 3 s and off for 3 s).After centrifuging the lysate at 12,000 rpm/min for 20 minutes, it was filtered through a sterilizing filter. In the affinity chromatography column, the filtrate was mixed with Ni2+-NTA Agarose 6FF (Shanghai Yuanye Bio - Technology Co., Ltd) for 30 minutes. A Tris·HCl buffer solution containing 20 mM imidazole was used as the washing buffer to elute the non-target proteins. A Tris·HCl buffer solution containing 50 mM, 100 mM, 200 mM, 300 mM or 400 mM imidazole was used as the elution buffer to elute the target protein bound to the nickel column. The purification effect was analyzed by SDS-PAGE. The His-tagged CAR-2 protein was dialyzed overnight in a PBS buffer solution (pH 7.4) using a dialysis bag. The concentration of the recombinant CAR-2 protein was determined by a Nano-300 Micro-Spectrophotometer.
Determination of kinetic parameters
Kinetic assays were conducted with a UV-1100 spectrophotometer as previously described ().β-Lactam hydrolysis was detected by monitoring the variation in absorbance using the characteristic molecular extinction coefficient to substrates: cefalothin (Δϵ260nm=-14,300 M-1cm-1); cefuroxime (Δϵ274nm=-18,600 M-1cm-1); cefotaxime sodium (Δϵ264nm=-11,625 M-1cm-1). The assays were conducted at 25°C with 3 ml of reaction mixture in 50mM HEPES buffer, pH 7.5 containing CAR-2 protein (0.634µM for cefalothin;1.27µM for cefuroxime; 0.634µM for cefotaxime sodium), 50µM ZnSO4.The steady-state kinetic parameters (vmax and km) were calculated after direct fit of the Michaelis-Menten equation on the experimental data with the program GraphPad. The value of kcat was obtained by dividing vmax by the CAR-2 protein concentration.
Construction of E.coli DH5α (pBluescript/IR111-CmR) and E.coli DH5α (pBluescript/CARR-IR111-CmR) for MIC experiments
To demonstrate that CARR binds IR111 (the 111- bp sequence of the interval between CARR and blaCAR-2) and inhibits the expression of the chloramphenicol resistance gene CmR, we constructed E.coli DH5α (pBluescript/IR111-CmR) and E.coli DH5α (pBluescript/CARR-IR111-CmR). In brief, the IR111 fragment and IR111-CARR fragment were amplified from P. diazotrophicus Pd1 genomic DNA using primers IR111-F, IR111-R and IR111-F, IR111-CARR-R, respectively. The CmR coding frame sequence was amplified from the pDM4 plasmid using primers CmR-F and CmR-R. IR111 and CmR were ligated to pBluescript double-digested with KpnI and SacII by ligase independent cloning (LIC) with ClonExpress MultiS One Step Cloning Kit (Vazyme Biotech Co., Ltd).Likewise, IR111-CARR and CmR were ligated into the pBluescript vector. The two recombinant plasmids were subsequently introduced into E.coli DH5α by heat shock. Finally, the MIC values of chloramphenicol in E. coli DH5α (pBluescript/IR111-CmR) and E. coli DH5α (pBluescript/CARR-IR111-CmR) were determined by the plate agar dilution method.
Construction of the CARR deletion mutant strain(ΔCARR)
The construction of ΔCARR was carried out according to homologous recombination. In brief, a upstream 583 bp fragment and a downstream 635 bp fragment of CARR were amplified from P. diazotrophicus Pd1 genomic DNA with primers CARR-up-F, CARR-up-R, and primers CARR-down-F, CARR-down-R, respectively. These two fragments and a tetracycline resistance cassette, which was amplified with CARR-TC-F and CARR-TC-R, were ligated into Suicide pDM4 plasmid by LIC with ClonExpress MultiS One Step Cloning Kit. The recombinant plasmids were subsequently introduced into P. diazotrophicus Pd1 strains by electrotransformation. The bacterial solution was subsequently spread on LB agar plates containing tetracycline (20µg/mL) and piperacillin (24µg/mL). A single colony was subcultured for 5 generations in liquid LB medium. Then, 20µl of bacterial culture was spread on LB agar plates containing tetracycline (20µg/mL). Chromosomal DNA of the transformants was checked by PCR with primers CARR-Delete-F and CARR-Delete-R. The primers used in this study are listed in Supplementary Table S1.
RNA isolation and quantitative PCR
RNA extraction was performed using the FreeZol Reagent (Vazyme Biotech Co., Ltd) according to the Manufacturer’ instructions. The RNA concentration was analyzed using a Nano-300Micro-Spectrophotometer. Subsequently, 500 ng of total RNA was reverse transcribed into cDNA with the HiScript III RT SuperMix for qPCR(+gDNA wiper) kit (Vazyme Biotech Co., Ltd). Real time quantitative PCR (qPCR) was performed using a fully-automated real-time fluorescent quantitative PCR analysis system Gentier 96 (Tianlong Technology Co., Ltd, Xi’an, China) with ChamQ Blue Universal SYBR qPCR Master Mix (Vazyme Biotech Co., Ltd) in 50 ng of cDNA. The primers used are detailed in Supplementary Table S1. Data normalization was performed using 16S rRNA (a housekeeping gene), and relative gene expression was calculated using the 2–ΔΔCt approach.
Statistical analysis
Student’s t-tests was used to evaluate the statistical significance of differences. A P-value < 0.05 was considered to indicate a statistically significant difference.
Results
Sequence features of CAR-2
The 990-bp blaCAR-2 encodes a 330-residue protein, which the highest sequence identity (60.82%) with subclass B3 MBLs CAR-1, as shown in Figure 1. Compared with that in CAR-1, the N-terminus of CAR-2 lacks a segment of 10 residues, LPSQGTETKG. CAR-2 shows lower identity to other subclass B3 MBLs, with identity scores ranging from 27.99% (AIM-1) to 34.85% (BJP-1). The novel CAR-2 was predicted to have two zinc-binding motifs: His136, His138, His211, Asp140,His141, and His276, as shown in Figure 1. The estimated theoretical isoelectric point and molecular weight of CAR-2 without the predicted signal peptide were 7.28 and 33.717 kDa, respectively. CAR-2 is speculated to possess three external loops (eLs), namely eL1- eL3 (; ), as shown in Figure 1.
Figure 1
Characterization of the MBL CAR-2
To clarify the substrate specificity of CAR-2, we constructed E.coli DH5α(pHSG398::CAR-2), which expressed CAR-2, and tested the MIC values for 14 β-lactam antibiotics. Compared with those for E.coli DH5α and E. coli DH5α(pHSG398), the MIC values for E.coli DH5α(pHSG398::CAR-2) increased significantly only for cefalothin, cefuroxime and cefotaxime sodium by 2-, 16- and 32- fold, respectively (Table 1). This result indicates that cefalothin, cefuroxime and cefotaxime are substrates of CAR-2. To confirm that CAR-2 is a MBL, we measured MICs in the presence of EDTA. Compared with those for E. coli DH5α(pHSG398::CAR-2) without EDTA, the MIC values for cefalothin, cefuroxime and ceftriaxone sodium in the presence of EDTA dropped to baseline levels (Table 1). This confirms that EDTA inhibited CAR-2 catalytic activity, indicating that CAR-2 is a MBL.
Table 1
| Antibiotic | MIC (µg/mL) | |||
|---|---|---|---|---|
| E.coli DH5α | E.coli DH5α (pHSG398) | E.coli DH5α (pHSG398::CAR-2) | E.coli DH5α (pHSG398::CAR-2)+EDTA* | |
| Ampicillin | 16 | 16 | 16 | 16 |
| Piperacillin | 0.5 | 0.5 | 0.5 | 0.5 |
| Carbenicillin | 4 | 4 | 4 | 4 |
| Cefalothin | 4 | 4 | 8 | 4 |
| Cefoxitin | 8 | 8 | 8 | 8 |
| Cefuroxime | 2 | 2 | 32 | 2 |
| Cefotaxime sodium | 0.0156 | 0.0156 | 0.5 | 0.0156 |
| Ceftazidime | 0.125 | 0.125 | 0.125 | 0.125 |
| Ceftazidime/ Clavulanic Acid | 0.125 | 0.125 | 0.125 | 0.125 |
| Cefepime | 0.32 | 0.32 | 0.32 | 0.32 |
| Aztreonam | 0.032 | 0.032 | 0.032 | 0.032 |
| Meropenem | 0.125 | 0.125 | 0.125 | 0.125 |
| Ertapenem | 0.032 | 0.032 | 0.032 | 0.032 |
| Imipenem | 0.25 | 0.25 | 0.25 | 0.25 |
The MIC values of antibiotics for different transformants of E. coli DH5α.
*Indicates that the final concentration of EDTA is 200 µM.
To determine the catalytic active site of CAR-2, we constructed six single mutants: E.coli DH5α[pHSG398::CAR-2(H136A)], E.coli DH5α[pHSG398::CAR-2(H138A)], E. coli DH5α [pHSG398::CAR-2(H211A)], E. coli DH5α [pHSG398::CAR-2(D140A)], E. coli DH5α[pHSG398::CAR-2(H141A)], and E. coli DH5α[pHSG398::CAR-2(H276A)], as shown in Supplementary Figure S1. Subsequently, we tested the MICs for cefuroxime and cefotaxime sodium. Cefuroxime susceptibility results revealed that compared with E. coli DH5α(pHSG398::CAR-2), mutants H136A, D140A and H211A showed the greatest MIC reduction- dropping the baseline levels, H138A and H276A showed moderate decreases, and H141A the least (Table 2). Cefotaxime MICs mirrored this trend. We conclude that these six residues are active sites, with H136, D140, and H211 being the primary zinc-binding sites.
Table 2
| Various mutants strains | MIC (µg/mL) | |
|---|---|---|
| Cefuroxime | Cefotaxime sodium | |
| H136A | 2 | 0.016 |
| H138A | 4 | 0.032 |
| D140A | 2 | 0.016 |
| H141A | 8 | 0.064 |
| H211A | 2 | 0.016 |
| H276A | 4 | 0.032 |
The MIC values of antibiotics for various mutants of CAR-2 on the pHSG398 plasmid in E. coli DH5α.
CAR-2 hydrolyzed cefalothin, cefuroxime and cefotaxime
We successfully induced the recombinant CAR-2 protein, and the size of this protein is consistent with the expected molecular weight of approximately 35 kDa, as shown in Supplementary Figure S2. To demonstrate that CAR-2 acted as a MBL can hydrolyze cefalothin, cefuroxime and cefotaxime, we performed CAR-2 enzymatic kinetic experiments. kcat was 0.84S-1 and kcat/km was 1.32×104 M-1·S-1 for cefalothin; kcat was 0.21 S-1 and kcat/km was 4.26×103 M-1·S-1 for cefuroxime; and kcat was 0.61 S-1, kcat/km was 1.87×104 M-1·S-1 for cefotaxime sodium, as shown in Table 3. When 1 mM of EDTA was added to the above reaction solution, no activity was observed, indicating that the CAR-2 enzyme requires zinc ions.
Table 3
| Substrate | Vmax(µM·S-1) | kcat (S-1) | km(µM) | kcat/km(M-1·S-1) |
|---|---|---|---|---|
| Cefalothin | 0.53 | 0.84 | 63.78 | 1.32×104 |
| Cefuroxime | 0.27 | 0.21 | 49.28 | 4.26×103 |
| Cefotaxime sodium | 0.39 | 0.62 | 33.08 | 1.87×104 |
| Cefepime | ND | NH | ND | ND |
Kinetic parameters of CAR-2.
NH, no hydrolysis detected; ND, data could not be determined.
CARR inhibited the expression of blaCAR-2
Through alignment analysis using DNAMAN software, the amino acid sequence of this CARR showed 63.76% similarity to that of the LysR-type transcriptional regulator (ECA2848)) located directly upstream of CAR-1. However, the CARR protein was poorly conserved with β-lactamase transcriptional regulators such as AmpR, VarR, and NmcR. The antibiotic sensitivity results showed that the MIC values of chloramphenicol for E.coli DH5α(pBluescript/IR111-CmR) and E.coli DH5α(pBluescript/CARR-IR111-CmR) were 120 µg/mL and 30 µg/mL, respectively, as shown in Figure 2. In the presence of CARR, the MIC of chloramphenicol decreased 4-fold (P < 0.001). These results indicate that CARR likely inhibits blaCAR-2 expression through the IR111 promoter. We successfully constructed the CARR deletion mutant strain, as shown in Supplementary Figure S3. To further prove that CARR inhibits the expression of blaCAR-2, we used qPCR to detect the mRNA expression of 16S rRNA and blaCAR-2 in P. diazotrophicus Pd1 wild-type strain andΔCARR, as shown in Supplementary Figure S4. Compared with that of the wild-type strain, the mRNA expression of blaCAR-2 in the ΔCARR strain increased approximately 10-fold (P < 0.01), as shown in Figure 3, indicating that CARR inhibited blaCAR-2 expression.
Figure 2

MIC values of E.coli DH5α (pBluescript/IR111-CmR) and E.coli DH5α (pBluescript/CARR-IR111-CmR) for chloramphenicol (*** denotes P < 0.001).
Figure 3

Determination of mRNA expression of blaCAR-2 in P. diazotrophicus Pd1 wild-type strain and ΔCARR (** denotes P < 0.01).
CARR reduced resistance to cefalothin, cefuroxime and cefotaxime
In order to clarify the association between CARR and cefalothin, cefuroxime and cefotaxime sodium, the MIC values of cefalothin, cefuroxime and cefotaxime sodium of P. diazotrophicus wild-type strain and ΔCARR strain were determined. Compared with those of the wild-type strain, the MIC values of the ΔCARR strain for cefalothin, cefuroxime and cefotaxime sodium increased 8-,8- and 16-fold, respectively, as shown in Table 4. These results demonstrated that CARR reduced the resistance to cefalothin, cefuroxime and cefotaxime sodium. Therefore, we conclude that CARR inhibits the expression of blaCAR-2, which reduces the resistance of P. diazotrophicus to cefalothin, cefuroxime and cefotaxime.
Table 4
| Various strains | MIC (µg/mL) | ||
|---|---|---|---|
| Cefalothin | Cefuroxime | Cefotaxime sodium | |
| WT | 4 | 4 | 0.0156 |
| ΔCARR | 32 | 32 | 0.25 |
Analysis of the impact of knocking out CARR on the MIC values of cefalothin, cefuroxime and cefotaxime in P. diazotrophicus.
Discussion
Subclass B1 prefers penicillin and cephalosporins as substrates, subclass B2 prefers carbapenems as substrates, and subclass B3 prefers penicillin as a substrate (
Subclasses B1 and B3 bind to two zinc ions, whereas subclass B2 binds to a single zinc ion (
The monometallic (zinc) form of subclass B2 MBLs exhibits a high degree of specificity for carbapenem antibiotics (
The substrate-binding pocket differs among the three subclasses and is especially important for substrate specificity and drug resistance (
The fifth gene, upstream of blaCAR-2 gene, encodes an IS3 family transposase, IS Ehe3, which can promote the horizontal movement of blaCAR-2 between the genomes of different bacteria. This result was consistent with previous findings stating that blaCAR-1 can be horizontally transmitted between bacteria via a horizontally acquired genomic island (HAI12) (
AmpC synthesis is activated in the presence of β-lactam antibiotics as a result of AmpR derepression. This mechanism involves disruption of the peptidoglycan by β-lactams that leads to increased periplasmic accumulation of cell wall precursors and degradation products (muropeptides). Within the cytoplasm, muropeptides derepress AmpR leading to induction of AmpC (
Conclusion
CAR-2 is a novel CAR family MBL that exhibits catalytic activity against cephalothin, cfuroxime and cefotaxime, and is strongly inhibited by EDTA. These six residues His136, His138, His211, Asp140, His141, and His276 are active sites, with His136, Asp140, and His211 being the primary zinc-binding sites. The inhibition of blaCAR-2 expression by CARR may act directly through the blaCAR-2 promoter, which reduces the resistance of P. diazotrophicus to cephalothin, cefuroxime and cefotaxime. This provided a theoretical basis for revealing new mechanisms of pathogen resistance.
Statements
Data availability statement
The draft complete sequences of P. diazotrophicus Pd1 was deposited in NCBI GenBank under the accession number: PRJNA1020661.
Ethics statement
The manuscript presents research on bacteria that do not require ethical approval for their study.
Author contributions
JL: Methodology, Writing – original draft, Conceptualization, Funding acquisition. CL: Writing – review & editing, Data curation. JZ: Writing – review & editing.
Funding
The author(s) declare financial support was received for the research and/or publication of this article. This research was funded by Quanzhou Science and Technology Project (no: 2023N046S) and Joint Funds for the Innovation of Science and Technology, Fujian Province (no: 2024Y9466).
Acknowledgments
We express our gratitude for the assistance provided by Professor Yang Huiyong’s team.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2025.1616646/full#supplementary-material
References
1
Almuzara MC. R.TragliaG.HaimM. S.De BelderD.AlvarezC.de Lourdes ReynalO.et al. (2024). Phytobacter spp: the emergence of a new genus of healthcare-associated Enterobacterales encoding carbapenemases in Argentina: a case series. Infect. Prev. Pract.6, 100379. doi: 10.1016/j.infpip.2024.100379
2
AmblerR. P. (1980). The structure of beta-lactamases. Philos. Trans. R Soc. Lond B Biol. Sci.289, 321–331. doi: 10.1098/rstb.1980.0049
3
BebroneC. (2007). Metallo-b-lactamases(classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem. Pharmacol.74, 1686–1701. doi: 10.1016/j.bcp.2007.05.021
4
BerglundF.JohnningA.LarssonD. G. J.KristianssonE. (2021). An updated phylogeny of the metallo-β-lactamases. J. Antimicrob. Chemother.76, 117–123. doi: 10.1093/jac/dkaa392
5
BushK.JacobyG. A. (2010). Updated functional classification of β-lactamases. Antimicrob. Agents Chemother.54, 969–976. doi: 10.1128/AAC.01009-09
6
DietzH.PfeifleD.WiedemannB. (1997). The signal molecule for beta-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide. Antimicrob. Agents Chemother.41, 2113–2120. doi: 10.1128/AAC.41.10.2113
7
FisherJ. F.MerouehS. O.MobasheryS. (2005). Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity. Chem. Rev.105, 395–424. doi: 10.1021/cr030102i
8
FonsecaF.BromleyE. H.SaavedraM. J.CorreiaA.SpencerJ. (2011). Crystal structure of Serratia fonticola sfh-I: a ctivation of the nucleophile in mono-zinc metallo β-lactamases. J. Mol. Biol.411, 951–959. doi: 10.1016/j.jmb.2011.06.043
9
GarauG.BebroneC.AnneC.GalleniM.FrèreJ. M.DidebergO. (2005). A metallo-beta-lactamase enzyme in action: Crystal structures of the monozinc carbapenemase CphA and its complex with biapenem. J. Mol. Biol.345, 785–795. doi: 10.1016/j.jmb.2004.10.070
10
HonP.KoK. K. K.ZhongJ. C. W.DeP. P.SmitsT. H. M.LowJ.et al. (2023). Genomic identification of two phytobacter diazotrophicusIsolates from a neonatal intensive care unit in Singapore. Microbiol. Resour Announc12, e001672. doi: 10.1128/mra.00167-23
11
JacobsC.FrèreJ. M.NormarkS. (1997). Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in gram-negative bacteria. Cell88, 823–832. doi: 10.1016/S0092-8674(00)81928-5
12
KrcoS.DavisS. J.JoshiP.WilsonL. A.Monteiro PedrosoM.DouwA.et al. (2023). Structure, function, and evolution of metallo-β-lactamases from the B3 subgroup-emerging targets to combat antibiotic resistance. FrontChem11, 1196073. doi: 10.3389/fchem.2023.1196073
13
KubotaH.NakayamaT.AriyoshiT.UeharaS.UchitaniY.TsuchidaS.et al. (2023). Emergence of Phytobacter diazotrophicus carrying an IncA/C(2) plasmid harboring blaNDM-1 in Tokyo, Japan. MSphere8, e0014723. doi: 10.1128/msphere.00147-23
14
KumarasamyK. K.TolemanM. A.WalshT. R.BagariaJ.ButtF.BalakrishnanR.et al. (2010). Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis.10, 597–602. doi: 10.1016/S1473-3099(10)70143-2
15
LeeJ. H.TakahashiM.JeonJ. H.KangL. W.SekiM.ParkK. S.et al. (2019). Dual activity of PNGM-1 pinpoints the evolutionary origin of subclass B3 metallo-β-lactamases: a molecular and evolutionary study. Emerg. Microbes Infect.8, 1688–1700. doi: 10.1080/22221751.2019.1692638
16
LinH. V.Massam-WuT.LinC. P.WangY. A.ShenY. C.LuW. J.et al. (2017). The Vibrio cholerae var regulon encodes a metallo-β-lactamase and an antibiotic efflux pump, which are regulated by VarR, a LysR-type transcription factor. . PloS One12, e0184255. doi: 10.1371/journal.pone.0184255
17
LinJ.WuJ.GongL.LiX.WangG. (2024). Sepsis caused by Phytobacter diazotrophicus complicated with galactosemia type 1 in China: a case report. BMC Infect. Dis.24, 599. doi: 10.1186/s12879-024-09458-y
18
LisaM. N.HemmingsenL.VilaA. J. (2010). Catalytic role of the metal ion in the metallo-beta-lactamase GOB. J. Biol. Chem.285, 4570–4577. doi: 10.1074/jbc.M109.063743
19
MartínezJ. L. (2018). Ecology and evolution of chromosomal gene transfer be tween environmental microorganisms and pathogens. Microbiol. Spectr.6, 10.1128. doi: 10.1128/microbiolspec.mtbp-0006-2016
20
MillerZ. R.O’DwyerJ. P. (2024). Metabolic trade-offs can reverse the resource-diversity relationship. Am. Nat.204, E85–E98. doi: 10.1086/732110
21
MojicaM. F.RossiM. A.VilaA. J.BonomoR. A. (2022). The urgent need for metallo-β-lactamase inhibitors: An unattended global threat. Lancet Infect. Dis.22, e28–e34. doi: 10.1016/S1473-3099(20)30868-9
22
Morán-BarrioJ.GonzálezJ. M.LisaM. N.CostelloA. L.PeraroM. D.CarloniP.et al. (2007). The metallo-beta-lactamase GOB is a mono-Zn(II) enzyme with a novel active site. J. Biol. Chem.282, 18286–18293. doi: 10.1074/jbc.M700467200
23
PedrosoM. M.WaiteD. W.MelseO.WilsonL.MitićN.McGearyR. P.et al. (2020). Broad spectrum antibiotic-degrading metallo-beta-lactamases are phylogenetically diverse. Protein Cell11, 613–617. doi: 10.1007/s13238-020-00736-4
24
PillonettoM.ArendL. N.FaoroH.D’EspindulaH. R. S.BlomJ.SmitsT. H. M.et al. (2018a). Emended description of the genus Phytobacter, its type species Phytobacter diazotrophicus (Zhang 2008) and description of Phytobacter ursingii sp. nov. Int. J. Syst. Evol. Microbiol.68, 176–184. doi: 10.1099/ijsem.0.002477
25
PillonettoM.ArendL.GomesS. M. T.OliveiraM. A. A.TimmL. N.MartinsA. F.et al. (2018b). Molecular investigation of isolates from a multistate polymicrobial outbreak associated with contaminated total parenteral nutrition in Brazil. BMC Infect. Dis.18, 397. doi: 10.1186/s12879-018-3287-2
26
RajerF.SandegrenL. (2022). The role of antibiotic resistance genes in the fitness cost of multiresistance plasmids. mBio13, e0355221. doi: 10.1128/mbio.03552-21
27
RanjanV. K.MukherjeeS.ThakurS.GuptaK.ChakrabortyR. (2021). Pandrug-resistant Pseudomonas spp. expresses New Delhi Metallo-β-lactamase-1 and consumes ampicillin as sole carbon source. Clin. Microbiol. Infect.27, 472.e1–472.e5. doi: 10.1016/j.cmi.2020.10.032
28
RanjanR.ThatikondaS. (2021). β-lactam resistance gene NDM-1 in the aquatic environment: A review. Curr. Microbiol.78, 3634–3643. doi: 10.1007/s00284-021-02630-6
29
SomboroA. M.Osei SekyereJ.AmoakoD. G.EssackS. Y.BesterL. A. (2018). Diversity and proliferation of metallo-β-lactamases: a clarion call for clinically effective metallo-β-lactamase inhibitors. Appl. Environ. Microbiol.84, e00698–e00618. doi: 10.1128/AEM.00698-18
30
SS.NH.FasimA.MoreSSDas MitraS. (2023). Identification of a potential inhibitor for New Delhi metallo-β-lactamase 1 (NDM-1) from FDA approved chemical library- a drug repurposing approach to combat carbapenem resistance. J. Biomol Struct. Dyn.41, 7700–7711. doi: 10.1080/07391102.2022.2123402
31
StoczkoM.FrèreJ. M.RossoliniG. M.DocquierJ. D. (2008). Functional diversity among metallo-beta-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora. Antimicrob. Agents Chemother.52, 2473–2479. doi: 10.1128/AAC.01062-07
32
WangM.ChenX.FangY.ZhengX.HuangT.NieY.et al. (2024). The trade-off between individual metabolic specialization and versatility determines the metabolic efficiency of microbial communities. Cell Syst.15, 63–74.e5. doi: 10.1016/j.cels.2023.12.004
33
WangB.HuangB.ChenJ.LiW.YangL.YaoL.et al. (2019). Whole-genome analysis of the colonization-resistant bacterium Phytobacter sp. SCO41T isolated from Bacillus nematocida B16-fed adult Caenorhabditis elegans. Mol. Biol. Rep.46, 1563–1575. doi: 10.1007/s11033-018-04574-w
34
YongD.TolemanM. A.BellJ.RitchieB.PrattR.RyleyH.et al. (2012). Genetic and biochemical characterization of an acquired subgroup B3 metallo-beta-lactamase gene, blaAIM-1, and its unique genetic context in Pseudomonas aeruginosa from Australia. Antimicrob. Agents Chemother.56, 6154–6159. doi: 10.1128/AAC.05654-11
35
YunY.HanS.ParkY. S.ParkH.KimD.KimY.et al. (2022). Structural insights for core scaffold and substrate specificity of B1, B2,and B3 metallo-β-lactamases. Front. Microbiol.12, 752535. doi: 10.3389/fmicb.2021.752535
Summary
Keywords
P. diazotrophicus, LysR-type transcriptional regulator CARR, metallo-β-lactamases (MBLs), blaCAR-2, antibiotic resistance
Citation
Lin J, Lin C and Zheng J (2025) LysR-type transcriptional regulator CARR represses the expression of blaCAR-2 and reduces P. diazotrophicus resistance to cefalothin, cefuroxime and cefotaxime. Front. Cell. Infect. Microbiol. 15:1616646. doi: 10.3389/fcimb.2025.1616646
Received
23 April 2025
Accepted
11 August 2025
Published
01 September 2025
Volume
15 - 2025
Edited by
Michael Marceau, Université Lille Nord de France, France
Reviewed by
Emily Stevens, Keele University, United Kingdom
Mohamed Mohamed Adel El-Sokkary, Mansoura University, Egypt
Updates

Check for updates
Copyright
© 2025 Lin, Lin and Zheng.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jiansheng Lin, 63678462@qq.com; Jingyang Zheng, 279277481@qq.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.